Congratulations to AstraZeneca on the expansion of Healthy Heart Africa! It’s incredibly impressive that this initiative has screened more than 50 million people for hypertension and trained more than 11,000 healthcare workers over the past 10 years – and will now be taking on chronic kidney disease. As Dr. Aceng, Uganda’s Minister of Health stated when discussing the rise of non-communicable diseases in Africa: “Prevention, prevention, prevention is the way to go to make sure our populations stay alive and thrive.” We were pleased to attend this session during the World Health Assembly co-hosted by AZ and the Uganda Ministry of Health which featured panelists from the Renal Patients Society of Kenya, WHO, Amref Health Africa, PATH, and AZ and keynote addresses from the Ministers of Health of Egypt and Uganda. Learn more about the Healthy Heart Africa program: www.astrazeneca.com Photo caption: Tackling the rise of NCDs in Africa
Rabin Martin’s Post
More Relevant Posts
-
🌟 icddr,b’s Annual Report 2023 is Here! 🔬 Milestone Achievement: “I am proud to note that through icddr,b research the Government of Bangladesh was able to eliminate Kala-azar as a public health threat, making Bangladesh the first country in the world to achieve this status. This milestone reflected over a decade of icddr,b’s pioneering research and innovative treatment strategies. It is in our plans to collaborate with other countries that are affected and help them combat this infectious disease.” — 𝘕𝘢𝘯𝘤𝘺 𝘠. 𝘊𝘩𝘦𝘯𝘨, 𝘍𝘊𝘗𝘈, 𝘍𝘊𝘈, 𝘊𝘩𝘢𝘪𝘳, 𝘉𝘰𝘢𝘳𝘥 𝘰𝘧 𝘛𝘳𝘶𝘴𝘵𝘦𝘦𝘴 🌍 Transformative Year: “2023 has been a transformative year for icddr,b, with strategic advances in scientific research and public health initiatives targeting global health challenges, particularly focused on low- and middle-income countries. Our achievements include breakthroughs in vaccines and health interventions, enhancing health outcomes in Bangladesh and beyond. Collaborations with over 175 international institutions, including more than 30 in the Global South, have strengthened our fight against infectious diseases, maternal and child health challenges, and chronic illnesses. Publishing over 450 articles in high-impact journals highlights our research strength”. — 𝘋𝘳. 𝘛𝘢𝘩𝘮𝘦𝘦𝘥 𝘈𝘩𝘮𝘦𝘥, 𝘌𝘹𝘦𝘤𝘶𝘵𝘪𝘷𝘦 𝘋𝘪𝘳𝘦𝘤𝘵𝘰𝘳 📖 Discover more about icddr,b’s initiatives and achievements in tackling global health challenges and improving health outcomes from our Annual Report.👉 Read the full Annual Report: https://lnkd.in/gQdcmwGU
To view or add a comment, sign in
-
-
MD|clinical research|one health|global health & infectious diseases|AMR & NTDs advocate|public health|epidemiology|biostatistics|
🌐African youth AMR forum 1.0🌐🌐🌐 Yesterday was the first day of the conversation at the African youth AMR forum 1.0. I'm so excited to be part of this 3 days forum organised by International Pharmaceutical Students' Federation , with invited experts from all over Africa under the theme of "meaningful youth engagement to prevent antimicrobial resistance together". This activity is coinciding with the world AMR awareness week. Antimicrobial resistance (AMR) is one of the greatest threats to public health, sustainable development, and security worldwide. The meaningful engagement of the youth community play a central role in preventing the emergence and spread of AMR. African Union Centers for Disease Control and Prevention West African Health Organization IVSA Standing Committee on One Health (SCOH) Actions des Jeunes contre la Résistance aux Antimicrobiens - AJRAM ReAct - Action on Antibiotic Resistance Federation of African Medical Students' Associations (FAMSA) Ducit Blue Foundation #AMR #WAAW2023 #RAM #togetheragainstAMR
To view or add a comment, sign in
-
-
We're thrilled to announce a major advancement in the treatment of post-kala-azar dermal leishmaniasis (PKDL), a stigmatizing skin disease. A clinical trial in Sudan, conducted by Drugs for Neglected Diseases initiative - DNDi and the Institute of Endemic Diseases at the University of Khartoum, has found a shorter, safer, and more effective treatment for PKDL. This new regimen reduces hospitalization days by over 50%, is child-friendly, can be delivered in primary healthcare facilities, and mitigates the safety risks associated with long antimonial therapy. With up to 98% cure rates, this new approach promises to transform the lives of many, especially children. Read more about this groundbreaking study published in PLOS Neglected Tropical Diseases journal. 🔗 https://bit.ly/4cOpWYD #beatNTDs #HopeforLeishmaniasis World Health Organization TDR Agence Française de Développement Médecins Sans Frontières (MSF) GOV.UK Swiss Agency for Development and Cooperation
To view or add a comment, sign in
-
-
AstraZeneca’s Healthy Heart Africa programme was established in 2014 as a response to Africa’s increasing burden of cardiovascular diseases. Over the past decade, the programme has expanded into 9 African countries, screening more than 54.4 million people for high blood pressure, training more than 11,480 healthcare workers, and activating 1,516 healthcare facilities to provide hypertension services. These efforts have identified more than 10.8 million people with high blood pressure by mid-2024, while driving patients to diagnosis linked to evidence-based treatment. In line with AstraZeneca's commitment to promoting health equity and supporting regional strategies and goals, the Healthy Heart Africa programme has evolved to include capacity and capability building, investment in improved screening and diagnostics, and the integration of screening for chronic kidney disease (CKD) to address a broader spectrum of non-communicable diseases (NCDs). To ensure a comprehensive approach to NCDs, including CKD, AstraZeneca continues to work collaboratively with local, national, and international partners and stakeholders, including government bodies, patient groups, and non-governmental organisations. HHA will expand to new countries in Northern Africa to align with global health objectives and reinforce the programme's commitment to promoting health equity and supporting regional strategies and goals. Join Us in Building a Healthier Future and learn more about the programme success here: Healthy Heart Africa - Access to Healthcare - AstraZeneca #HealthyHeartAfrica #NCDs #EquityInHealth Pelin Incesu Qutaiba Al Manaseer Ahmed Kishta Basma Shams Chloe Jolley Maria Nauss
To view or add a comment, sign in
-
-
AMREF and GSK are set to co-host a side event at #wha77 to address the urgent global health crisis posed by antimicrobial resistance (AMR), particularly acute in low—and middle-income countries. With Africa projected to bear the highest burden of AMR-related deaths by 2050, coordinated strategies and collective action are critical. The session will spotlight insights and gather inputs to bolster AMR action across Africa. As part of the "African Leadership for AMR Action" initiative, a 13-month endeavour, we aim to strengthen locally led AMR programs informed by a region-wide landscape analysis. Discussions will focus on priority strategic information and the design of a messaging framework, culminating in the formation of a regional action group. By convening high-level stakeholders from government, civil society, and the private sector, we aim to align on key priorities and mobilize support for AMR response. Register for #amrefatwha77 session via https://lnkd.in/dquGpBGu World Health Organization Africa CDC
To view or add a comment, sign in
-
-
Today, the Belgian Presidency of the Council of the EU has adopted conclusions with a strong commitment to preventative action against non-communicable diseases (NCDs). This is a monumental step in addressing the growing impact of NCDs on European populations, societies, and economies. ECDA Chairman Raymond Vanholder stated, “Today’s adoption of the Council Conclusions is a significant recognition of the need to stimulate Europe’s efforts to reduce the prevalence of NCDs in our societies and commitment to achieve progress. ECDA thanks the Council for maintaining political focus and urgency on this issue." As the Council leadership prepares to shift, we encourage future Presidencies to keep NCD prevention as a key priority. Let's continue making progress towards healthier communities, stronger workforces, and more resilient national healthcare systems. 📌 Read ECDA's full statement here: https://bit.ly/3Leus6N
To view or add a comment, sign in
-
Advance in management of neglected tropical diseases should be celebrated this findings on the treatment of post-kala-azar dermal leishmaniasis is one such public health win. Kudos to Drugs for Neglected Diseases initiative - DNDi for this research work.
We're thrilled to announce a major advancement in the treatment of post-kala-azar dermal leishmaniasis (PKDL), a stigmatizing skin disease. A clinical trial in Sudan, conducted by Drugs for Neglected Diseases initiative - DNDi and the Institute of Endemic Diseases at the University of Khartoum, has found a shorter, safer, and more effective treatment for PKDL. This new regimen reduces hospitalization days by over 50%, is child-friendly, can be delivered in primary healthcare facilities, and mitigates the safety risks associated with long antimonial therapy. With up to 98% cure rates, this new approach promises to transform the lives of many, especially children. Read more about this groundbreaking study published in PLOS Neglected Tropical Diseases journal. 🔗 https://bit.ly/4cOpWYD #beatNTDs #HopeforLeishmaniasis World Health Organization TDR Agence Française de Développement Médecins Sans Frontières (MSF) GOV.UK Swiss Agency for Development and Cooperation
To view or add a comment, sign in
-
-
Hotgen: Empowering the Global Response to Mpox The recent declaration by the World Health Organization (WHO) recognizing the mpox (monkeypox) outbreak as a Public Health Emergency of International Concern (PHEIC, https://lnkd.in/dN45XXQM) underscores the urgency and gravity of the situation in Africa and in the world. Realizing this severe situation, as always, Beijing Hotgen Biotech Co., Ltd. (Hotgen) offers innovative and reliable diagnostic solutions to aid in the detection and containment of global pandemics. Our primary products are 3 tests as below: l PCR Kits: detect mpox virus DNA with high sensitivity and specificity, providing a definitive diagnosis and enabling targeted public health interventions. l Antigen Tests: offer immediate results, facilitating efficient screening and early identification of potential cases. l Antibody IgM/IgG Tests: offer quick results to determine past exposure to mpox virus, aiding in epidemiological studies and vaccine development efforts. Key Advantages of Hotgen Biotech's Solutions: l High Sensitivity and Specificity: Ensuring accurate detection even at low viral loads, minimizing false negatives and false positives. l Short Turnaround Time: Results available within minutes, enabling prompt patient management and containment strategies. l User-Friendly Operations: Intuitive and easy-to-use formats, ensuring accessibility for healthcare professionals across various settings. PCR tests are compatible with mainstream devices in market. l International Standards: CE-IVD certified products, adhering to stringent European regulatory standards for in vitro diagnostic devices. Hotgen is open to collaborate with healthcare organizations, governments, and all entities worldwide to support mpox detection and containment efforts. We offer our diagnostic solutions at competitive prices and provide comprehensive technical support to ensure optimal utilization. Together, we can make a difference in the fight against mpox. Contact Hotgen today to learn more about our solutions and how we can support your efforts in protecting public health. #Mpox #healthemergency Understanding the PHEIC Declaration: The WHO's PHEIC designation signifies a significant and imminent threat to global public health. It serves as a call to action, prompting coordinated international efforts to control the spread of the virus and mitigate its impact on communities worldwide. This designation highlights the importance of early detection, effective surveillance, and timely response measures. https://lnkd.in/gcZRF5gG
World Health Organization (WHO)
facebook.com
To view or add a comment, sign in
-
The Joint Action JARDIN, launched on March 8, 2024, aims to integrate European Reference Networks (ERNs) into national health systems. The expected results from JARDIN, including recommendations, blueprints and reports from concrete pilot implementations are to stimulate the elaboration of improved national plans for rare diseases in EU Member States. The European Reference Networks (ERNs) are virtual networks involving healthcare providers across Europe. They aim to facilitate discussion on complex or rare diseases and conditions that require highly specialised treatment, and concentrated knowledge and resources. 24 ERNs are working on a range of thematic issues, including ERN-LUNG - European Reference Network for rare respiratory diseases, the European Reference Center for Rare Lung Diseases, which includes a core network on #pulmonaryhypertension. Five pulmonary hypertension patients/patient advocates sit on the ERN-LUNG Patient Advocacy Group, see list at this link: https://lnkd.in/dieSgfa9 Hall Skaara PHA Europe Natalia Maeva PHA Europe Gergely Meszaros JD, MSc Tüdőér Egylet Luc MATTHYSEN HTAP Belgique Pisana Ferrari Alliance for Pulmonary Hypertension https://lnkd.in/ddKJFJiT
Kick-off meeting of the EU Joint Action JARDIN on the integration of European Reference Networks (ERNs) into national health systems
http://ph-ksp.com
To view or add a comment, sign in
-
📢 EU4Health Civil Society Alliance Priority 2: Health promotion and prevention should have a budget allocated at the EU level and be reflected in investments and economic discourse. #Health of all citizens underpins our well being and our Union’s economic success. Dedicated funding to safeguard our health is critical to make the priorities of #EU citizens achievable! 💶 A dedicated EU budget should be allocated for health promotion and prevention. This should align with the expectations of citizens, given that two-thirds of Europeans desire increased efforts towards improving health and well-being. 📖 Read our manifesto: https://lnkd.in/eBqGfu8s 📝Sign here: https://lnkd.in/eBheKK6r #EU4HealthCSOs #EU4HealthCSA #EU4Health #EU2024 #EUElections #EU2024Elections European Patients' Forum, EURORDIS-Rare Diseases Europe Alzheimer Europe, EUPHA - European Public Health Association, EuroHealthNet, European AIDS Treatment Group, Smoke Free Partnership, Health Action International, Association of European Cancer Leagues European Alcohol Policy Alliance - Eurocare, European Heart Network (EHN), European Cancer Patient Coalition , ENSP - European Network for Smoking and Tobacco Prevention, Association of European Coeliac Societies , EUROCAM, European Cancer Organisation, European Chronic Disease Alliance, European Federation of Allergy and Airways Diseases Patients' Associations (EFA), European Federation of Neurological Associations, EHMA - European Health Management Association, EKHA - European Kidney Health Alliance, European Liver Patients' Association - ELPA, European Respiratory Society, International Diabetes Federation Europe ISCA - International Sport and Culture Association, IVAA | International Federation of Anthroposophic Medical Associations, Mental Health Europe, PAREA, TB Europe Coalition, Wemos, Association ŠKUC, Eurasian Harm Reduction Association, ESWA, FONDAZIONE VILLA MARAINI, Greek Patients Association, Háttér Társaság
To view or add a comment, sign in
Partner at Rabin Martin
3moTerrific session and tremendous passion from health leaders!